Results 1 to 10 of about 9,806 (132)

Implications of NKG2A in immunity and immune-mediated diseases

open access: yesFrontiers in Immunology, 2022
In recent studies, NKG2A is revealed to be a key immune checkpoint for both natural killer (NK) cells and CD8+ T cells. It form heterodimer receptors with CD94, and targets the peptide-presenting human leukocyte antigen-E (HLA-E) molecules.
Zhaochen Ning   +2 more
exaly   +3 more sources

CD8+ T Cells Form the Predominant Subset of NKG2A+ Cells in Human Lung Cancer

open access: yesFrontiers in Immunology, 2020
Background: NKG2A is an inhibitory receptor of both T cells and natural killer (NK) cells. Persistent activation promotes T cells and NK cells to express NKG2A and results in the progression of chronic infection and cancer.
Pin Wu, Lijian Huang, Lufeng Zhao
exaly   +3 more sources

NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions

open access: yesCell Reports, 2021
Summary: Human Vδ2 cells are innate-like γδ T effectors performing potent immune surveillance against tumors. The constitutive expression of NKG2A identifies a subset of Vδ2 T cells licensed with an intrinsic hyper-responsiveness against cancer.
, Domenico Mavilio, Lorenzo Bello
exaly   +3 more sources

Co-editing of NKG2A and FAS increases long-term cytotoxic capacity and persistence of CAR NK cells [PDF]

open access: yesMolecular Therapy: Oncology
Natural killer (NK) cells have the intrinsic ability to kill cancer cells and are thus targeted in immunotherapy. Anti-CD19 CAR NK cells have shown efficacy in clinical studies in treating B cell malignancies; however, the full cytotoxic capacities of ...
Juliane Mietz   +11 more
doaj   +2 more sources

NKG2A Expression Is Not per se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an In Vitro System Mimicking the Tumor Microenvironment

open access: yesFrontiers in Immunology, 2018
Natural killer (NK) cell-based immunotherapy is a promising therapy for cancer patients. Inhibitory killer immunoglobulin-like receptors (KIRs) and NKG2A are required for NK cell licensing, but can also inhibit NK cell effector function.
Marcel Tilanus   +2 more
exaly   +3 more sources

The inhibitory receptor NKG2A is expressed on T-cells during BKPyVANephropathy [PDF]

open access: yesFrontiers in Immunology
IntroductionBKPyV-associated nephropathy (BKPyVAN) is a major complication in kidney transplantation. An exhaustion of BKPyV-specific T-cells but not T-cells against other viruses is observed, suggesting a mechanism specifically mediated by BKPyV ...
Karen Bargiel   +18 more
doaj   +2 more sources

Longitudinal Dynamics of NK-Cell Regulatory Signaling and IVIG Response in Kawasaki Disease [PDF]

open access: yesChildren
Background and Objectives: Kawasaki disease (KD) is an acute systemic vasculitis in children, and approximately 10–20% of patients develop resistance to intravenous immunoglobulin (IVIG), which is associated with an increased risk of coronary artery ...
Yeonju Kim   +4 more
doaj   +2 more sources

Improvement of NK Cell Cytotoxicity in Reconstituting NK Cells after Allogeneic Stem Cell Transplantation by Blocking NKG2A Checkpoint [PDF]

open access: yesMiddle East Journal of Cancer, 2023
Background: One cause of tumor relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the alteration of the graft-versus-tumor effect of early reconstituting natural killer (NK) cells due to overexpression of the NKG2A inhibitory
Mohammed Taha, Cyril Fauriat
doaj   +1 more source

KIR+CD8+ and NKG2A+CD8+ T cells are distinct innate-like populations in humans

open access: yesCell Reports, 2023
Summary: Subsets of the human CD8+ T cell population express inhibitory NK cell receptors, such as killer immunoglobulin-like receptors (KIRs) and NKG2A.
Seong Jin Choi   +7 more
doaj   +1 more source

Comprehensive Pan-Cancer Analysis Reveals the Potential Biological, Immunological, and Prognostic Value of NKG2A

open access: yesAnalytical Cellular Pathology, 2023
Background. NKG2A (KLRC1) belongs to the NKG2 family, which has been shown to affect the activity of natural killer (NK) cells and CD8T cells. However, a comprehensive biological analysis and exploration of NKG2A in different cancers is lacking and this ...
Yao Rong   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy